These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8795023)

  • 1. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T.
    Pan JW; Hetherington HP; Vaughan JT; Mitchell G; Pohost GM; Whitaker JN
    Magn Reson Med; 1996 Jul; 36(1):72-7. PubMed ID: 8795023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.
    Sarchielli P; Presciutti O; Pelliccioli GP; Tarducci R; Gobbi G; Chiarini P; Alberti A; Vicinanza F; Gallai V
    Brain; 1999 Mar; 122 ( Pt 3)():513-21. PubMed ID: 10094259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T.
    Hetherington HP; Mason GF; Pan JW; Ponder SL; Vaughan JT; Twieg DB; Pohost GM
    Magn Reson Med; 1994 Nov; 32(5):565-71. PubMed ID: 7808257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
    Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
    Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
    PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    De Stefano N; Matthews PM; Fu L; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL
    Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
    Willemsen MA; Van Der Graaf M; Van Der Knaap MS; Heerschap A; Van Domburg PH; Gabreëls FJ; Rotteveel JJ
    AJNR Am J Neuroradiol; 2004 Apr; 25(4):649-57. PubMed ID: 15090362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.
    Pan JW; Coyle PK; Bashir K; Whitaker JN; Krupp LB; Hetherington HP
    Mult Scler; 2002 May; 8(3):200-6. PubMed ID: 12120690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.
    Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schild HH; Träber F
    J Neurol; 2008 Jan; 255(1):56-63. PubMed ID: 18080854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
    Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G
    Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.